Evidence map›Paper›PMID 41776386›Full record

ArticleCell transplantation

Long-term outcomes of autologous cell transplantation for patients with non-TAO autoimmune disease-related critical limb ischemia.

Hao Liu, Lingwei Zou, Yuan Fang, Gang Fang, Yifan Liu, Xiaolang Jiang, Bin Chen, Zheng Wei, Shiyang Gu, Peng Liu and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hao LiuDepartment of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Lingwei ZouDepartment of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Yuan FangDepartment of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Gang FangDepartment of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Yifan LiuDepartment of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Xiaolang JiangDepartment of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Bin ChenDepartment of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Zheng WeiDepartment of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China.
Shiyang GuDepartment of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China.
Peng LiuDepartment of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China.
Weiguo FuDepartment of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Tianyue PanDepartment of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhihui DongDepartment of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.ORCID 0000-0002-3754-2458

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune disease-related critical limb ischemia (AD-CLI) represents a significant portion of no-option critical limb ischemia (NO-CLI). Despite the demonstrated safety and efficacy of cell transplantation for NO-CLI, most studies focused on thromboangiitis obliterans (TAO). There remains a scarcity of reports on cell transplantation for AD-CLI induced by systemic lupus erythematosus (SLE), hypereosinophilic syndrome (HES), and so on. From May 2011 to May 2024, 22 patients with 36 ischemic limbs were enrolled. The primary outcome was amputation, whereas secondary outcomes included toe-brachial index (TBI), Wong-Baker Faces Pain Rating Scale (WBFPS), transcutaneous oxygen pressure (TcPO

Indexed as

Autoimmune DiseasesIschemiaTransplantation, AutologousAdultAgedFemaleHumansMaleMiddle AgedTreatment Outcomeautoimmune diseasecell transplantationcritical limb ischemiasystemic lupus erythematosus

Identifiers

PMID41776386
PMCPMC12961100

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.